American Diabetes Association Says Mifepristone Shown To Reduce A1C In Patients With Difficult-To-Control Type 2 Diabetes And Hypercortisolism

• AMERICAN DIABETES ASSOCIATION: MIFEPRISTONE SHOWN TO REDUCE A1C IN PATIENTS WITH DIFFICULT-TO-CONTROL TYPE 2 DIABETES AND HYPERCORTISOLISM

North AmericaReuters

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Show more

Login or create a forever free account to read this news

Let's go

---

More news from Reuters